Diagnostic and prognostic validity of the human papillomavirus E6/E7 mRNA test in cervical cytological samples of HC2-positive patients

Cancer Causes and Control

Volumn 22, Issue 6, 2011, Pages 869-875

  Benevolo, Maria ^a   Terrenato, Irene ^a   Mottolese, Marcella ^a   Marandino, Ferdinando ^a   Carosi, Mariantonia ^a   Rollo, Francesca ^a   Ronchetti, Livia ^a   Muti, Paola ^a   Mariani, Luciano ^a   Sindico, Stefano ^a   Vocaturo, Giuseppe ^a   Vocaturo, Amina ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervical lesions; Diagnostic biomarker; HPV E6 E7 mRNA; Human papillomavirus; Prognostic biomarker

Indexed keywords

MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; COLPOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA CYTOLOGY; VALIDATION STUDY; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYTODIAGNOSIS; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; FEMALE; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRESSOR PROTEINS; RNA, MESSENGER; RNA, VIRAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79956283084     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9757-0     Document Type: Article

References (29)

1. JM Walboomers MV Jacobs MM Manos, et al. 1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 12 19 10451482 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 1:STN:280:DyaK1Mzot1CjsQ%3D%3D (Pubitemid 29406813)
2. D Solomon M Schiffman R Tarone 2001 Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial J Natl Cancer Inst 93 293 299 11181776 10.1093/jnci/93.12.951-a 1:STN:280:DC%2BD3M7psFCgsg%3D%3D (Pubitemid 32219816)
3. D Saslow CD Runowicz D Solomon, et al. 2002 American Cancer Society guideline for the early detection of cervical neoplasia and cancer CA Cancer J Clin 52 342 362 12469763 10.3322/canjclin.52.6.342 (Pubitemid 35446606)
4. J Cuzick A Szarewski H Cubie, et al. 2003 Management of women who test positive for high-risk types of human papillomavirus: the HART study Lancet 362 1871 1876 14667741 10.1016/S0140-6736(03)14955-0 1:STN:280: DC%2BD3sroslajtw%3D%3D (Pubitemid 37518501)
5. G Ronco P Giorgi-Rossi F Carozzi, et al. 2006 New Technologies for Cervical Cancer screening Working Group. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial Lancet Oncol 7 547 555 16814206 10.1016/S1470-2045(06)70731-8 (Pubitemid 43923665)
6. JW Sellors TL Karwalajtys J Kaczorowski, et al. 2003 Incidence, clearance and predictors of human papillomavirus infection in women CMAJ 168 421 425 12591782 (Pubitemid 36255727)
7. MA Nobbenhuis TJ Helmerhorst AJ van den Brule, et al. 2001 Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear Lancet 358 1782 1783 11734239 10.1016/S0140-6736(01) 06809-X 1:STN:280:DC%2BD3MnoslOrsw%3D%3D (Pubitemid 33153007)
8. Kjaer SK, van den Brule AJ, Paull G et al. (2002) Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325:572
9. J Cuzick C Clavel KU Petry, et al. 2006 Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 1095 1101 16586444 10.1002/ijc.21955 1:CAS:528:DC%2BD28Xns1CmsLg%3D (Pubitemid 44116919)
10. M von Knebel Doeberitz 2002 New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections Eur J Cancer 38 2229 2242 10.1016/S0959-8049(02)00462-8 (Pubitemid 35346464)
11. AK Lie G Kristensen 2008 Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma Expert Rev Mol Diagn 8 405 415 18598223 10.1586/14737159.8.4.405 1:CAS:528:DC%2BD1cXotFOqt7k%3D (Pubitemid 351962087)
12. PE Castle J Dockter C Giachetti, et al. 2007 A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer Clin Cancer Res 13 2599 2605 17473189 10.1158/1078-0432.CCR-06-2881 1:CAS:528:DC%2BD2sXkslOhtLc%3D (Pubitemid 46788025)
13. K Cuschieri N Wentzensen 2008 Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17 2536 2545 18842994 10.1158/1055-9965.EPI-08-0306 1:CAS:528:DC%2BD1cXht1egt7rM
14. CM Ho BH Lee SF Chang, et al. 2010 Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia Int J Cancer 127 622 632 19960432 10.1002/ijc.25078 1:CAS:528: DC%2BC3cXmslSnt7Y%3D
15. MA de Boer ES Jordanova GG Kenter, et al. 2007 High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients Clin Cancer Res 13 132 138 17200347 10.1158/1078-0432.CCR-06-1568 (Pubitemid 46121861)
16. A Szarewski L Ambroisine L Cadman, et al. 2008 Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomarkers Prev 17 3033 3042 18957520 10.1158/1055-9965.EPI-08- 0508 1:CAS:528:DC%2BD1cXhtlCkur%2FM
17. D Solomon D Davey R Kurman, et al. 2002 The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2114 2119 11966386 10.1001/jama.287.16.2114 (Pubitemid 34437346)
18. S Rosini R Zappacosta G Di Bonaventura, et al. 2007 Management and triage of women with human papillomavirus infection in follow-up for low-grade cervical disease: association of HPV-DNA and RNA-based methods Int J Immunopathol Pharmacol 20 341 347 17624246 1:CAS:528:DC%2BD2sXptFGlurw%3D (Pubitemid 47104854)
19. P Cattani GF Zannoni C Ricci, et al. 2009 Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix J Clin Microbiol 47 3895 3901 19828739 10.1128/JCM.01275-09
20. AD Varnai M Bollmann A Bankfalvi, et al. 2008 Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications Oncol Rep 19 457 465 18202795 (Pubitemid 351176108)
21. KS Cuschieri MJ Whitley HA Cubie 2004 Human papillomavirus type specific DNA and RNA persistence implications for cervical disease progression and monitoring J Med Virol 73 65 70 15042650 10.1002/jmv.20062 1:CAS:528: DC%2BD2cXjslertr4%3D (Pubitemid 38429149)
22. T Molden I Kraus F Karlsen H Skomedal JF Nygard B Hagmar 2005 Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4, 136 women &;30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion Cancer Epidemiol Biomarkers Prev 14 367 372 15734959 10.1158/1055-9965.EPI-04-0410 1:CAS:528:DC%2BD2MXhs1Ghs7o%3D (Pubitemid 40270098)
23. AK Lie B Risberg B Borge, et al. 2005 DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia Gynecol Oncol 97 908 915 15943992 10.1016/j.ygyno.2005.02.026 1:CAS:528:DC%2BD2MXltFSgs7o%3D (Pubitemid 40824665)
24. P Halfon D Benmoura A Agostini, et al. 2010 Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay J Clin Virol 47 177 181 20022804 10.1016/j.jcv.2009.11.011 1:CAS:528:DC%2BC3cXntVCisg%3D%3D
25. G Ronco N Segnan P Giorgi-Rossi, et al. 2006 Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial J Natl Cancer Inst 98 765 774 16757701 10.1093/jnci/djj209 (Pubitemid 43983300)
26. G Ronco P Giorgi-Rossi F Carozzi, et al. 2008 Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test J Natl Cancer Inst 100 492 501 18364502 10.1093/jnci/djn065
27. RG Pretorius YP Bao JL Belinson, et al. 2007 Inappropriate gold standard bias in cervical cancer screening studies Int J Cancer 12 2218 2224 10.1002/ijc.22991 (Pubitemid 47585601)
28. J Cuzick M Arbyn R Sankaranarayanan, et al. 2008 Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 Suppl 10 K29 K41 18847555 10.1016/j.vaccine.2008.06.019
29. T Molden JF Nygard I Kraus, et al. 2005 Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL Pap smear Int J Cancer 114 973 976 15645423 10.1002/ijc.20839 1:CAS:528:DC%2BD2MXjsFWjs74%3D